Continuing Education for Hematology | Online CME Hematology Courses

Search

All France Foundation Content

Page 1 of 2

Results 1 - 75 of 80

9278-isth-explore

Hemophilia Gene Therapy: Shared Decision Making - Clinical Companion Guide

Understanding PNH and Other Complement-mediated Hematologic Disorders

Getting to Know PNH

Current and Emerging Treatment Options in PNH

Understanding Myelofibrosis

Risk Stratification in Myelofibrosis Management

Current and Emerging JAK Inhibitors

9278-isth-explore

Risks and Benefits of Hemophilia Gene Therapy: An EXPLORE Learning Experience

A Hematologic Emergency: Would You Miss iTTP? - Rapid Recap

cttp_thumb_264x150

cTTP: Protecting Patients, Today and Tomorrow - Rapid Recap

Rett Syndrome: Delayed Diagnosis, Patient Perspectives & Evolving Treatment - Rapid Recap

Rett Syndrome: Delayed Diagnosis, Patient Perspectives & Evolving Treatment - Slide Deck

Rett Syndrome: Delayed Diagnosis, Patient Perspectives & Evolving Treatment

A Hematologic Emergency: Would You Miss iTTP?

Identify the Etiology of Aplastic Anemia in Patients

Recognizing Risk and Benefits of Management Options for Aplastic Anemia

Considerations for Special Populations With Aplastic Anemia

9171-ash-explore

Gene Therapy for Hemophilia: An EXPLORE Learning Experience

cttp_thumb_264x150

cTTP: Protecting Patients, Today and Tomorrow

CAR T-Cell Therapy Consults: Navigating a New Landscape

9167-0001-263x149

Treating Persistent/Chronic ITP: Current Care, Future Potential

Strategies for Assessing and Managing DOAC-Related Bleeding

Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)

Emerging Treatments in Chronic GvHD

Treatment of Ph+ Relapsed/Refractory ALL

Treatment of Ph- Relapsed/Refractory ALL

Emerging Nonfactor Approaches for Patients with Hemophilia

Identification of Relapsed ALL

Principles of Management of Chronic GVHD

Diagnosing and Assessing Chronic Graft-versus-Host Disease

Reversing DOACS: Providing Answers to What, Where and How

Reversing DOACS: Recording from Live Session held on July 18, 2021

Conquer the Clot: Addressing VTE in Your Patients with Cancer

9076-0001-263x149

Healthcare Disparities in African Americans With Myeloma

Key Considerations: Advances in Gene Therapy for Hemophilia

Highlights From the EAHAD 2021 Virtual Congress

Updated Follow-up of the Alta Study, Giroctocogene Fitelparvovec (SB-525)

First Data From the Phase 3 HOPE-B Gene Therapy Trial

The World Federation of Hemophilia Gene Therapy Registry

Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Pipe)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Leebeek)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Miesbach)

First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology

Characterisation of Adeno-Associated Virus Vector Persistence

Follow-up on a Novel Adeno-Associated Virus (AAV) Gene Therapy (FLT180a)

Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Drygalski)

Efficacy and Safety of Etranacogene Dezaparvovec in Adults

Thrombotic Thrombocytopenic Purpura (TTP) Podcasts

Cancer-Associated Thrombosis: Catheter-related Thrombosis (CRT) VTE

Approach to the Patient With Cancer-associated VTE

Cancer-Associated Thrombosis: Primary Prophylaxis

Understanding and Recognizing TTP

How to Treat iTTP in 2020

TTP: Complexities and Comorbidities

Monitoring of Immnune Mediated TTP

Diagnosis of TTP

Key Considerations: Advances in Gene Therapy for Hemophilia

Integrating Emerging Treatments for Hemophilia A

Genomics Essentials In Hematologic Malignancies (GENOM)

Gene Therapy for Treatment of Hemophilia: An Introduction to AAV Vector Gene Transfer

Gene Therapy for Treatment of Hemophilia: Other Strategies and Targets

9915-conf_covg_icon_263x149

Conference Coverage from ISTH 2019 in Melbourne

A History of Hemophilia Treatment: Non-replacement Therapy to Gene Therapy

Gene Therapy for Treatment of Hemophilia: Common Concerns in Gene Therapy

A History of Hemophilia Treatment: Factor Replacement to Gene Therapy

Getting to Know Gene Therapy: Terminology and Concepts

Biosimilars: Applying the Science to Hematology/Oncology Practice

biosims-archmed icon

Top Questions about Biosimilars in Hematology/Oncology

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Page 1 of 2